Pear Therapeutics

$80$125

Pear Therapeutics operates in prescription digital therapeutics or PDTs market. It discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear’s lead product is, reSET®, for the treatment of substance use disorder

Report ID:

UMHE21952

Published:

Jan-2022

Pages:

13

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMHE21952 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Vision, Product Portfolio, and Business Headquarter
Information on its recent developments including partnerships, collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1. Key Facts of the Company
2. Company Mission
3. Company Value
4. Growth Strategy
5. Key Products & Services Offered
6. Infographic
7. Executive Team
8. SWOT Analysis
9. Recent Development
9.1 Product Launches
9.2 Partnership
9.3 Business Expansions & Investments
9.4 Mergers and Acquisitions

Companies Mentioned

“VR pain relief therapies
EtectRx
Groups Recover Together
Spectrum Health Systems
Novartis”